Home • Up • VEGF antibodies

Functional anti

 

VEGF Antibodies

FUNCTIONAL ANTIBODIES CONVENTIONAL ABS

List of Agonistic Antibodies

Antibody Name Catalogue Number Unit Size/Price

Agonistic Human VEGFR2 pV1001g-h 50mg/299€ + 85€ handling

(Polyclonal Ab)

Agonistic Human VEGFR2 mV1001.3m-h 200mg/399€ + 85€ handling

(Monoclonal Ab)

Agonistic Mouse VEGFR2 mV1001r-m 200mg/399€ + 85€ handling

(Monoclonal Ab)

Agonistic Human VEGFR1 mV1004m-h 200mg/399€ + 85€ handling

(Monoclonal Ab)

List of Antagonistic/Blocking Antibodies

Antibody Name Catalogue Number Unit Size/Price

Antagonistic Mouse PECAM-1 mP1001r-m 200mg/399€ + 85€ handling

(Monoclonal Ab)

Antagonistic Human VEGFR2 mV1001.1m-h 200mg/399€ + 85€ handling

(Monoclonal Ab)

Antagonistic Human VEGFR1 pV1004R-h 100mg/249€ + 85€ handling

(Polyclonal Ab)

Antagonistic Human Endoglin mT1001m-h 200mg/399€ + 85€ handling

(monoclonal Ab)

Blocking Antibody of Mouse PlGFNew mP1002r-m 200mg/399€ + 85€ handling

(monoclonal Ab)

human Activin A 100-310 5 210 14 anti-human CTGFL, pab 102-P110 100 270 26
human Adiponection 100-121 25 210 14 anti-mouse CTLA4, pab 103-P43 100 270 26
human AITRL 100-122 20 210 14 human CXCL16 100-148 25 210 27
human Ang-1 300-047 5 90 14 anti-human CXCL16, pab 100-P111 100 270 27
human Ang-1 300-048 20 265 14 mouse CXCL16 M10-056 25 210 27
human Ang-2 300-049 5 90 15 anti-mouse CXCL16, pab 103-P44 100 270 27
human Ang-2 300-050 20 245 15 human CYR61 100-149 20 210 27
human ApoA-I 100-123 100 210 15 bovine ECGF (Crude Extract) 300-090 15mg 70 208
human ApoE2 100-124 500 210 15 porcine ECGF (Crude Extract) 300-092 15mg 70 209
human ApoE3 100-125 500 210 15 human EGF 100-008 100 55 27
human ApoE4 100-126 500 210 16 human EGF 100-009 500 135 27
human Apo-SAA 100-127 500 210 16 anti-human EGF, pab 102-P06 100 270 28
mouse APRIL M10-050 20 210 16 mouse EGF M10-002 100 90 27
anti-human APRIL, pab 102-P210 100 270 16 mouse EGF M10-003 500 210 27
human Artemin 100-128 20 210 16 anti-mouse EGF, pab 103-P45 100 270 28
human 4-1BB receptor S01-039 20 210 17 human EG-VEGF 100-150 20 210 28
anti-human 4-1BB receptor, pab 102-P100 100 270 17 anti-human EG-VEGF, pab 102-P113 100 270 28
human 4-1BBL 100-001 20 210 17 human EMAP-II 100-010 20 210 28
anti-mouse B71, pab 103-P40 100 270 17 anti-human EMAP-II, pab 102-P114 100 270 28
human BAFF 100-002 20 210 18 human ENA-78/LIX 100-011 20 210 29
anti-human BAFF, mab 101-M18 500 250 18 anti-human ENA-78, pab 102-P07 100 270 29
anti-human BAFF, pab 102-P101 100 270 18 human Eotaxin-2 100-013 20 210 29
human sBAFF receptor S01-038 50 210 18 anti-human Eotaxin-2, mab 101-M01 500 250 29
human BCA-1 100-003 20 270 19 anti-human Eotaxin-2, pab 102-P09 100 270 29
anti-human BCA-1, pab 102-P01 100 210 19 mouse Eotaxin-2 M10-059 20 270 29
mouse BCA-1 M10-051 20 210 19 anti-mouse Eotaxin-2, pab 103-P48 100 210 29
human BCMA 100-131 5 210 19 human Eotaxin-3 100-014 20 210 30
human BD-1 (36aa) 100-132 20 210 19 anti-human Eotaxin-3, mab 101-M19 500 250 30
human BD-1 (47aa) 100-133 20 210 19 anti-human Eotaxin-3, pab 102-P10 100 270 30
anti-human BD2, pab 102-P103 100 270 20 human Exodus-2 100-015 20 210 30
human BD-2 100-004 20 210 19 anti-human Exodus-2, pab 102-P11 100 270 30
human BD-3 100-135 20 210 19 mouse Exodus-2 M10-005 20 210 30
human BDNF 100-005 10 210 20 anti-mouse Exodus-2, pab 103-P03 100 270 30
anti-human BDNF, pab 102-P02 100 270 20 human sFAS Ligand 100-157 10 210 31
human sBMP receptor-1A S01-021 100 285 21 anti-human sFAS Ligand, pab 102-P120 100 270 31
human BMP-2 200-001 5 90 20 human sFAS receptor S01-030 20 210 31
human BMP-2 200-002 25 350 20 human FGF-acidic 100-016 50 210 31
anti-human BMP-2/4, pab 102-PA90S 100 150 21 anti-human FGF-acidic, pab 102-P12 100 270 32
anti-human BMP-2/4, pab 102-PA90 200 225 21 human FGF-2 (basic) 300-001 10 80 32
anti-human BMP-2, pab 102-P03A 100 270 20 human FGF-2 (basic) 300-002 25 100 32
anti-human BMP-7, pab 102-P105 100 270 21 human FGF-2 (basic) 300-003 50 175 32
human BMP-13 100-137 50 210 21 anti-human FGF-2 (basic), pab 102-PA08S 100 150 32
human BRAK 100-139 20 210 22 anti-human FGF-2 (basic), pab 102-PA08 200 225 32
mouse mouse C-10 M10-001 10 210 22 anti-human FGF-2 (basic), mab 101-M70 500 250 32
anti-mouse anti-mouse C-10, pab 103-P01 100 270 22 anti-human FGF-2 (basic), pab 102-P13 100 270 32
human Cardiotrophin-1 100-140 10 210 22 human FGF-4 100-017 25 210 33
mouse Cardiotrophin-1 M10-052 10 210 22 human FGF-5 100-018 50 210 33
anti-human Cardiotrophin-1, pab 102-P04 100 270 23 anti-human FGF-5, mab 101-M71 500 250 34
human sCD105/Endoglin S01-024 5 75 24 human FGF-6 100-019 25 210 33
human sCD105/Endoglin S01-025 25 280 24 human FGF-7/KGF 100-163 10 210 34
anti-human sCD105/Endoglin, pab 102-PA60S 100 150 24 anti-human FGF-7/KGF, pab 102-P123 100 270 34
anti-human sCD105/Endoglin, pab 102-PA60 200 225 24 human FGF-8 100-020 25 210 33
anti-human sCD105/Endoglin, pab 102-PA60AG 50 210 24 human FGF-9 100-021 20 210 33
mouse sCD105/Endoglin S01-022 5 75 24 human FGF-9 300-007 5 80 33
mouse sCD105/Endoglin S01-023 25 280 24 human FGF-9 300-008 20 175 33
anti-mouse sCD105/Endoglin, mab 103-M60 100 230 24 mouse FGF-9 M10-006 10 210 33
anti-mouse sCD105/Endoglin, mab 103-MBi60 50 250 24 anti-mouse FGF-9, pab 103-P04 100 270 33
anti-mouse sCD105/Endoglin, pab 103-PA60S 100 150 24 human FGF-10 100-022 25 210 33
anti-mouse sCD105/Endoglin, pab 103-PA60 200 225 24 anti-human FGF-10, pab 102-P124 100 270 34
anti-mouse sCD105/Endoglin, pab 103-PA60AG 50 210 24 human FGF-16 100-023 25 210 33
human sCD22 S01-031 20 210 23 anti-human FGF-16, pab 102-P125 100 270 34
anti-human sCD22, pab 102-P107 100 270 23 human FGF-17 100-024 25 210 33
anti-human sCD40 Ligand, pab 102-P108 100 270 23 anti-human FGF-17, pab 102-P126 100 270 34
anti-human sCD40 Ligand, pab 102-P108G 100 270 23 human FGF-18 100-025 25 210 33
mouse sCD40 Ligand/TRAP M10-54 25 210 23 human FGF-19 100-169 25 210 33
human sCD40 Ligand/TRAP 100-115 50 210 23 human FGF-20 100-170 15 210 33
human CNTF 100-007 20 210 25 human sFGFR-1/Fc Chimera SFC-015 10 75 34
anti-human CNTF, pab 102-P05 100 270 25 human sFGFR-1/Fc Chimera SFC-016 50 235 34
rat CNTF R20-001 25 210 25 human sFGFR-2/Fc Chimera SFC-017 10 75 34
anti-rat CNTF, pab 104-P01 100 270 25 human sFGFR-2/Fc Chimera SFC-018 50 235 34
human CRP 100-144 10 210 25 human sFGFR-3/Fc Chimera SFC-019 10 75 34
human CTACK 100-145 20 210 25 human sFGFR-3/Fc Chimera SFC-020 50 235 34
mouse CTACK M10-055 20 210 25 human sFGFR-4/Fc Chimera SFC-021 10 75 35
human CTGF (98aa) 100-146 20 210 26 human sFGFR-4/Fc Chimera SFC-022 50 235 35
human CTGFL 100-147 20 210 26 human flt3-Ligand 100-026S 2 55 35

human flt3-Ligand 100-026 10 135 35 anti-human IGF-1, pab 102-P28 100 270 46
human flt3-Ligand 100-026-SC 50 375 35 mouse IGF-1 M10-011 50 210 46
anti-human flt3-Ligand, pab 102-P14 100 270 35 anti-mouse IGF-1, pab 103-P08 100 270 46
mouse flt3-Ligand M10-062 10 210 35 human IGF-2 100-041 50 210 46
human Follistatin 100-172 20 210 36 anti-human IGF-2, pab 102-P29 100 270 46
human Fractalkine (CX3C) 100-173 20 210 36 human IGF-BP1 100-197 25 210 47
anti-human Fractalkine, pab 102-P15 100 270 36 human IGF-BP2 100-198 25 210 47
human gAcrp30 100-174 25 210 36 human IGF-BP3 100-199 25 210 47
anti-human gAcep 30, pab 102-P129 100 270 37 anti-human IGF-BP-3, pab 102-P144 100 270 47
human gAcrp30 Variant 100-174a 25 210 36 human IGF-BP4 100-200 25 210 47
anti-human gAcep 30 Variant, pab 102-P130 100 270 37 human IGF-BP5 100-201 25 210 47
mouse gAcrp30 M10-063 25 210 36 human IGF-BP6 100-202 25 210 47
human Galectin-1 100-175 50 210 37 human IGF-BP7 100-203 25 210 47
anti-human Galectin-1, pab 102-P131 100 270 37 human IL-1 alpha 100-042 10 210 47
human Galectin-3 100-176 50 210 37 anti-human IL-1 alpha, pab 102-P30 100 270 48
human GCP-2 100-028 20 210 38 mouse IL-1 alpha M10-012 10 210 47
anti-human GCP-2, pab 102-P16 100 270 38 anti-mouse IL-1 alpha, pab 103-P10 100 270 48
human G-CSF 100-029 10 160 38 rat IL-1 alpha R20-024 10 210 47
anti-human G-CSF, pab 102-P17 100 270 38 anti-rat IL-1 alpha, pab 104-P22 100 270 48
mouse G-CSF M10-007 10 210 38 human IL-1 beta 400-001 2 55 48
anti-mouse G-CSF, pab 103-P05 100 270 38 human IL-1 beta 400-002 10 135 48
human GDF-3 100-179 20 210 39 human IL-1 beta 400-002-DC 50 395 48
human GDF-9 100-180 20 210 39 anti-human IL-1 beta, mab 101-M03 500 250 48
human GDF-11 100-181 20 210 39 anti-human IL-1 beta, pab 102-P31 100 270 48
human GDNF 100-030 10 210 40 mouse IL-1 beta M10-013 10 210 48
anti-human GDNF, pab 102-P18 100 270 40 anti-mouse IL-1 beta, pab 103-P11 100 270 48
human GM-CSF 200-004 2 55 40 rat IL-1 beta R20-005 10 210 48
human GM-CSF 200-005 10 135 40 anti-rat IL-1 beta, pab 104-P04 100 270 48
human GM-CSF 200-005-DC 50 375 40 human IL-1 receptor antagonist 100-043 20 210 49
human GM-CSF 400-010 2 65 40 human IL-2 200-009 5 70 49
human GM-CSF 400-010S 5 120 40 human IL-2 200-010 50 175 49
human GM-CSF 400-011 20 320 40 anti-human IL-2, mab 101-M04 500 250 49
human GM-CSF 400-011-DC 50 425 40 anti-human IL-2, pab 102-P148 100 270 49
anti-human GM-CSF, pab 102-P19 100 270 41 anti-human IL-2, pab 102-P32 100 270 49
mouse GM-CSF M10-008 10 210 40 mouse m IL-2 M10-014 20 210 49
anti-mouse GM-CSF, pab 103-P06 100 270 41 anti-mouse IL-2, pab 103-P12 100 270 49
rat GM-CSF R20-041 10 210 40 rat IL-2 R20-026 20 210 49
human GRO/MGSA 100-031 25 210 41 human h sIL-2 receptor S01-032 25 210 50
anti-human GRO/MGSA, pab 102-P20 100 270 41 human IL-3 200-015 2 55 50
human GRO-beta 100-032 10 210 41 human IL-3 200-015-SC 50 135 50
anti-human GRO-beta, pab 102-P21 100 270 41 human IL-3 200-016 10 375 50
human GRO-gamma 100-033 10 210 41 human IL-3 400-003S 2 60 50
anti-human GRO-gamma, pab 102-P22 100 270 41 human IL-3 400-003 5 90 50
rat GROß/MIP-2 R20-002 25 210 41 human IL-3 400-004 20 270 50
anti-rat GROß/MIP-2, pab 104-P02 100 270 41 human IL-3 400-004-SC 50 425 50
rat GRO/KC (CXCL1) R20-003 25 210 41 anti-human IL-3, pab 102-P33 100 270 51
anti-rat GROß/KC, pab 104-P20 100 270 41 mouse IL-3 M10-015 10 210 50
human HB-EGF 100-185 50 210 42 anti-mouse IL-3, pab 103-P13 100 270 51
human HCC-1 100-034 10 210 42 rat IL-3 beta R20-006 10 210 51
HeLa cells (5x10E9 cells) FER-001 240 211 anti-rat IL-3 beta, pab 104-P24 100 270 51
human Heregulin beta-1 100-187 50 210 42 human IL-4 200-021 2 55 51
human HGF 300-010 5 90 43 human IL-4 200-022 10 135 51
human HGF 300-011 25 350 43 human IL-4 200-023-DC 50 395 51
anti-human HGF, pab 102-PA62S 100 175 43 anti-human IL-4, mab 101-M05 500 250 51
anti-human HGF, pab 102-PA62 200 290 43 anti-human IL-4, pab 102-P34 100 270 51
anti-human HGF, pab 102-PA62AG 50 210 43 mouse IL-4 M10-016 10 210 51
anti His-tag, pab 102-PA80 50 120 210 anti-mouse IL-4, pab 103-P14 100 270 51
human I-309 100-035 10 210 43 rat IL-4 R20-007 10 210 51
anti-human I-309, pab 102-P24 100 270 43 anti-rat IL-4, pab 104-P05 100 270 51
human IFN-alpha 100-036 100 210 44 human sIL-4 receptor alpha S01-033 15 210 52
anti-human IFN-alpha, mab 101-M02 500 250 44 human IL-5 100-044 10 210 52
anti-human IFN-alpha, pab 102-P25 100 270 44 anti-human IL-5, pab 102-P35 100 270 52
human IFN-beta 100-037 10 210 44 human IL-6 200-030 2 45 52
human IFN-beta 100-191 10 210 44 human IL-6 200-031 20 135 52
anti-human IFN-beta, pab 102-P26 100 270 44 human IL-6 200-030-DC 50 375 52
human h IFN-gamma 100-039 100 210 45 anti-human IL-6, mab 101-M06 500 250 53
anti-human IFN-gamma, pab 102-P27 100 270 45 anti-human IL-6, pab 102-P153 100 270 53
mouse IFN-gamma M10-010 100 210 45 anti-human IL-6, pab 102-P36 100 270 53
anti-mouse IFN-gamma, pab 103-P07 100 270 45 mouse IL-6 M10-017 10 210 52
rat IFN-gamma R20-004 100 210 45 anti-mouse IL-6, pab 103-P15 100 270 53
anti-rat IFN-gamma, pab 104-P03 100 270 45 rat IL-6 R20-008 10 210 52
human IFN-lambda1 100-193 20 210 45 anti-rat IL-6, pab 104-P06 100 270 53
human IFN-lambda2 100-194 20 210 45 anti-rat IL-6, pab 104-P27 100 270 53
mouse IFN-lambda2 M10-068 20 210 45 human sIL-6 receptor alpha S01-034 20 210 53
human IGF-1 100-040 100 210 46 human IL-7 100-045 10 210 53

anti-human IL-7, mab 101-M07 500 250 54 anti-human LEC/NCC-4 102-P51 100 270 63
anti-human IL-7 102-P37 100 270 53 human Leptin 100-061 1000 210 64
mouse IL-7 M10-018 10 210 53 anti-human Leptin, mab 101-M74 500 250 64
anti-mouse IL-7, pab 103-P16 100 270 54 anti-human Leptin, pab 102-P52 100 270 64
rat IL-7 R20-029 10 210 53 mouse Leptin M10-028 1000 210 64
human IL-8 (72aa) 100-046 25 210 54 anti-mouse Leptin, pab 103-P24 100 270 64
human IL-8 (77aa) 100-047 25 210 54 rat Leptin R20-033 1000 210 64
anti-human IL-8, mab 101-M08 500 250 54 anti-rat Leptin, pab 104-P29 100 270 64
anti-human IL-8, pab 102-P38 100 270 54 mouse LIGHT M10-076 20 210 64
human IL-9 100-217 10 210 55 anti-human LIGHT, pab 102-P172 100 270 64
anti-human IL-9, pab 102-P155 100 270 55 mouse LIX/CXCL5 (70 aa) M10-030 20 210 29
mouse IL-9 M10-069 10 210 55 mouse LIX/CXCL5 (93 aa) M10-114 20 210 29
anti-mouse IL-9, pab 103-P57 100 270 55 anti-mouse LIX, pab 103-P26 100 270 29
human IL-10 100-049 10 210 55 human Lymphotactin 100-063 20 210 65
anti-human IL-10, pab 102-P40 100 270 55 anti-human Lymphotactin, pab 102-P54 100 270 65
mouse IL-10 M10-020 10 210 55 human sLYVE-1 S01-028 5 75 65
anti-mouse IL-10, pab 103-P18 100 270 55 human sLYVE-1 S01-029 25 280 65
rat IL-10 R20-009 10 210 55 anti-human Lyve-1, pab 102-PA50S 100 175 65
anti-rat IL-10, pab 104-P07 100 270 55 anti-human Lyve-1, pab 102-PA50 200 290 65
human IL-11 100-050 10 210 56 anti-human Lyve-1, pab 102-PA50AG 50 210 66
anti-human IL-11, mab 101-M09 500 250 56 anti-human Lyve-1, pab 102-PABi50 50 210 66
anti-human IL-11, pab 102-P41 100 270 56 mouse sLYVE-1 S01-026 5 75 65
human IL-12 100-051 10 210 56 mouse sLYVE-1 S01-027 25 280 65
anti-human IL-12, mab 101-M72 500 250 57 anti-mouse Lyve-1, pab 103-PA50S 100 175 65
anti-human IL-12, pab 102-P42 100 270 56 anti-mouse Lyve-1, pab 103-PA50 200 290 65
mouse IL-12 M10-021 10 210 56 anti-mouse Lyve-1, pab 103-PA50AG 50 210 66
anti-mouse IL-12, mab 103-M23 500 250 57 anti-mouse Lyve-1, pab 103-PABi50 50 210 66
anti-mouse IL-12, pab 103-P19 100 270 56 human MCP-1 (MCAF) 100-065 20 210 67
human IL-12p40 100-311 10 210 57 anti-human MCP-1, mab 101-M12 500 250 67
mouse IL-12p40 M10-070 10 210 57 anti-human MCP-1/MCAF, pab 102-P55 100 270 67
human IL-13 100-052 10 210 57 rat MCP-1 (MCAF) R20-010 10 210 67
anti-human IL-13, pab 102-P43 100 270 57 anti-rat MCP-1/MCAF, pab 104-P08 100 270 67
mouse IL-13 M10-071 10 210 57 human MCP-2 100-066 10 210 67
anti-mouse IL-13, pab 103-P60 100 270 57 anti-human MCP-2, mab 101-M75 500 250 67
rat IL-13 R20-031 10 210 57 anti-human MCP-2, pab 102-P56 100 270 67
human IL-15 100-053 10 210 58 mouse MCP-2 M10-075 20 210 67
anti-human IL-15, mab 101-M10 100 270 58 human MCP-3 100-067 10 210 67
anti-human IL-15, pab 102-P44 100 270 58 anti-human MCP-3, mab 101-M13 500 250 67
mouse IL-15 M10-022 10 210 58 anti-human MCP-3, pab 102-P177 100 270 67
rat IL-15 R20-032 10 210 58 anti-human MCP-3, pab 102-P57 100 270 67
human IL-16 100-054 10 210 58 mouse MCP-3 M10-031 10 210 67
anti-human a-h IL-16 102-P45 100 270 58 anti-mouse MCP-3, pab 103-P27 100 270 67
mouse IL-16 (130aa) M10-083 10 210 58 human MCP-4 100-068 10 210 67
human IL-17A 100-055 25 210 59 anti-human MCP-4, mab 101-M76 500 250 67
anti-human IL-17A, pab 102-P46 100 270 59 anti-human MCP-4, pab 102-P58 100 270 67
anti-human IL-17A, pab 102-P162 100 270 59 anti-human MCP-4, pab 102-P180 100 270 67
human IL-17B 100-225 25 210 59 mouse MCP-5 M10-032 20 210 67
human IL-17D 100-226 25 210 59 anti-mouse MCP-5, pab 103-P28 100 270 67
human IL-17E 100-227 10 210 59 human M-CSF 100-064S 2 55 66
anti-human IL-17E, pab 102-P163 100 270 60 human M-CSF 100-064 10 135 66
human IL-17F 100-228 10 210 60 anti-human M-CSF, pab 102-P60 100 270 66
anti-human IL-18BP, pab 102-P47 100 270 60 mouse M-CSF M10-078 10 210 66
human IL-19 100-229 10 210 60 anti-mouse M-CSF, pab 103-P63 100 270 66
human IL-20 100-230 10 210 60 human MDC (67 aa) 100-069 20 210 68
anti-human IL-20, pab 102-P165 100 270 61 human MDC (69 aa) 100-070 20 210 68
anti-human IL-22, pab 102-P166 100 270 61 anti-human MDC, mab 101-M77 500 250 68
mouse IL-22 M10-072 10 210 61 anti-human MDC, pab 102-P61 100 270 68
human IL-31 100-232 10 210 61 mouse MDC M10-033 20 210 68
mouse IL-31 M10-073 10 210 61 anti-mouse MDC, pab 103-P66 100 270 68
human IP-10 100-057 25 210 61 human MEC 100-246 20 210 68
anti-human IP-10, pab 102-P48 100 270 62 mouse MEC M10-090 20 210 68
mouse IP-10 M10-025 25 210 61 anti-mouse MECA32, mab 103-M42 100 230 68
anti-mouse IP-10, pab 103-P21 100 270 62 human MIA 100-247 20 210 69
human I-TAC 100-058 20 210 62 human Midkine 100-071 20 210 69
anti-human I-TAC, pab 102-P49 100 270 62 anti-human Midkine, pab 102-P183 100 270 69
mouse I-TAC/CXCL11 M10-086 20 210 62 human MIG 100-072 20 210 70
mouse JE (MCP-1) M10-026 100 210 67 anti-human MIG, mab 101-M78 500 250 70
anti-mouse JE (MCP-1), pab 103-P22 20 270 67 anti-human MIG, pab 102-P62 100 270 70
mouse KC (CXCL1) M10-027 20 210 41 mouse MIG M10-034 20 210 70
anti-mouse KC (CXCL1), pab 103-P23 100 270 41 human MIP-1 alpha 100-073 20 210 70
human LAG-1 100-234 20 210 62 anti-human MIP-1 alpha, mab 101-M14 500 250 71
human LD78beta/CCL3L1 100-235 20 210 63 anti-human MIP-1 alpha, pab 102-P63 100 270 71
anti-human LD78-beta, pab 102-P169 100 270 63 mouse MIP-1 alpha M10-035 10 210 70
human LEC/NCC-4 100-060 20 210 63 anti-mouse MIP-1 alpha, pab 103-P29 100 270 71
anti-human LEC, mab 101-M73 500 250 63 rat MIP-1 alpha R20-011 20 210 70

anti-rat MIP-1 alpha 104-P09 100 270 71 anti-human PlGF (nat), pab 102-PA04AG 50 180 82
human MIP-1 beta 100-074 10 210 71 anti-human Podoplanin, mab 101-M40 100 250 83
anti-human MIP-1 beta, pab 102-P64 100 270 71 anti-human Podoplanin Biotin, mab 101-MBi40 50 250 83
mouse MIP-1 beta M10-077 10 210 71 anti-human Podoplanin, pab 102-PA40S 100 175 83
rat MIP-1 beta R20-035 20 210 71 anti-human Podoplanin, pab 102-PA40 200 290 83
mouse MIP-1 gamma M10-036 20 210 72 anti-human Podoplanin, mab 103-M40 100 250 83
anti-mouse MIP-1 gamma, pab 103-P30 100 270 72 anti-human Podoplanin Biotin, mab 103-MBi40 50 250 83
mouse MIP-2 (CXCL2) M10-037 20 210 72 human Prokineticin-2 100-272 20 210 83
anti-mouse MIP-2/CXCL2, pab 103-P31 100 270 72 human Prolactin 100-273 20 210 84
human MIP-3 100-075 20 210 73 human Prox-1 (fragment) 300-052 5 70 84
anti-human MIP-3, pab 102-P66 100 270 73 anti-human Prox-1 (E,W,IF), pab 102-PA32S 100 150 84
anti-human MIP-3, pab 102-P66G 100 270 73 anti-human Prox-1 (E,W,IF), pab 102-PA32 200 225 84
human MIP-3 alpha 100-078 20 210 73 anti-human Prox-1 (E,W,IF), pab 102-PA32AG 50 175 84
anti-human MIP-3 alpha, mab 101-M79 500 250 73 anti-human Prox-1 (IHC), pab 102-PA30S 100 175 84
anti-human MIP-3 alpha, pab 102-P67 100 270 73 anti-human Prox-1 (IHC), pab 102-PA30 200 290 84
mouse MIP-3 alpha M10-100 20 210 73 human PTHrP 100-275 50 210 85
human MIP-3 beta 100-079 20 210 74 human sRANK receptor 100-117 20 210 86
anti-human MIP-3 beta, mab 101-M80 500 250 74 anti-human RANK receptor, pab 102-P206 100 270 86
anti-human MIP-3 beta, pab 102-P68 100 270 74 human sRANKL 100-276 10 210 85
mouse MIP-3 beta M10-079 20 210 74 anti-human sRANKL, mab 101-M82 500 250 85
anti-human MIP-4, pab 102-P69 100 270 74 anti-human sRANKL, pab 102-P204 100 270 85
human MIP-4 (PARC) 100-080 10 210 74 anti-human sRANKL, pab 102-P205 100 270 85
human MIP-5 100-081 25 210 75 mouse sRANKL M10-080 10 210 85
anti-human MIP-5, pab 102-P70 100 270 75 anti-mouse sRANKL, pab 103-P71 100 270 85
human Myostatin 100-255 10 210 75 human RANTES 100-095 20 210 86
human NAP-2 100-082 10 210 75 anti-human RANTES, mab 101-M16 500 250 86
anti-human NAP-2, mab 101-M81 500 250 76 anti-human RANTES, pab 102-P80 100 270 86
anti-human NAP-2, pab 102-P71 100 270 76 anti-mouse RANTES, pab 103-P32 100 270 86
anti-human NAP-2, pab 102-P191 100 270 76 anti-rat RANTES, pab 104-P10 100 270 86
human Neurturin 100-083 10 210 76 mouse RANTES M10-038 20 210 86
anti-human Neurturin, pab 102-P72 100 270 76 rat RANTES R20-012 20 210 86
human NGF-beta 100-084 20 210 76 human RELM alpha 100-279 20 210 87
anti-human NGF-beta, pab 102-P73 100 270 76 mouse RELM alpha M10-081 20 210 87
human NNT-1/BCSF-3 100-259 10 210 77 mouse RELM beta M10-082 20 210 87
human NOGGIN 100-260 20 210 77 anti-mouse RELM beta, pab 103-P50 100 270 87
human NP-1 100-085 20 210 77 human Resistin 100-280 25 210 87
anti-human NP-1, pab 102-P194 100 270 77 anti-human Resistin, pab 102-P92 100 270 88
human NT-3 100-086 10 210 78 mouse Resistin M10-084 25 210 87
anti-human NT-3, pab 102-P74 100 270 78 anti-mouse Resistin, pab 103-P51 100 270 88
anti-human NT-3, pab 102-P196 100 270 78 human SCF 100-097S 2 55 88
human NT-4 100-087 10 210 78 human SCF 100-097 10 135 88
anti-human NT-4, mab 101-M15 500 250 78 human SCF 100-097-SC 50 395 88
anti-human NT-4, pab 102-P75 100 270 78 human SCF 400-013S 2 65 88
anti-human NT-4, pab 102-P198 100 270 78 human SCF 400-013 5 120 88
human Oncostatin M 100-088 10 210 79 human SCF 400-014 20 320 88
anti-human Oncostain M, pab 102-P76 100 270 79 human SCF 400-014-SC 50 425 88
human Osteoprotegerin (OPG) 100-089 50 210 79 anti-human SCF, mab 101-M83 500 250 89
anti-human OPG, pab 102-P200 100 270 79 anti-human SCF, pab 102-P81 100 270 89
human PDGF-AA 200-051S 2 55 80 anti-human SCF, pab 102-P81G 100 270 89
human PDGF-AA 200-051 5 90 80 mouse SCF M10-039 10 210 88
human PDGF-AA 200-052 20 350 80 anti-mouse SCF, pab 103-P33 100 270 89
anti-human PDGF-AA, pab 102-P77 100 270 80 rat SCF R20-040 10 210 88
human PDGF-AB 200-053S 2 55 80 anti-rat SCF, pab 104-P30 100 270 89
human PDGF-AB 200-053 5 90 80 human SCGF-alpha 100-098 10 210 89
human PDGF-AB 200-054 20 350 80 anti-human SCGF-alpha, pab 102-P93 100 270 89
human PDGF-BB 200-055S 2 55 80 human SCGF-beta 100-096 10 210 89
human PDGF-BB 200-055 5 90 80 human SDF-1 alpha 100-099 10 210 89
human PDGF-BB 200-056 20 350 80 anti-human SDF-1 alpha, pab 102-P82 100 270 90
anti-human PDGF-BB, pab 102-P78 100 270 80 mouse SDF-1 alpha M10-040 10 210 89
human Persephin (PSP) 100-120 20 210 80 anti-mouse SDF-1 alpha, pab 103-P34 100 270 90
human PF-4 100-093 20 210 81 human SDF-1 beta 100-100 10 210 90
anti-human PF-4, pab 102-P79 100 270 81 anti-human SDF-1 beta, pab 102-P83 100 270 90
human Pleiotrophin 100-094 20 210 81 mouse SDF-1 beta M10-085 10 210 90
human PIGF-1 300-015S 2 80 81 mouse SF20 M10-092 10 210 90
human PIGF-1 300-015 5 160 81 human TACI 100-285 20 210 91
human PIGF-1 300-016 20 490 81 anti-human TACI, pab 102-P94 100 270 91
human PIGF-1/His 300-017S 2 70 81 human TARC 100-101 20 210 91
human PIGF-1/His 300-017 5 130 81 anti-human TARC, pab 102-P84 100 270 91
human PIGF-1/His 300-018 20 425 81 human TECK 100-102 20 210 92
human PIGF-2 300-019S 2 80 82 anti-human TECK, mab 101-M84 500 250 92
human PIGF-2 300-019 5 160 82 anti-human TECK, pab 102-P85 100 270 92
human PIGF-2 300-020 20 490 82 human TFF-1 100-288 20 210 92
anti-human PlGF, apb 102-PA01S 100 150 82 human TFF-2 100-289 20 210 92
anti-human PlGF, pab 102-PA01 200 225 82 human TGF-alpha 100-103 100 210 93
anti-human PlGF (nat), pab 102-PA04S 100 150 82 anti-human TGF-alpha, pab 102-P86 100 270 93

human TGF-beta1 300-023 5 210 93 anti-human VEGF-A, pab 102-PA02 200 225 104
anti-mouse TGF-beta1, mab 101-M85 100 250 93 anti-human VEGF-A, pab 102-PA03S 100 150 104
human TGF-beta2 100-105 5 210 94 anti-human VEGF-A, pab 102-PA03 200 225 104
human TGF-beta3 100-107 5 210 94 anti-mouse VEGF-A, pab 103-PA03S 100 150 104
human sTIE-1/Fc Chimera SFC-011 20 100 94 anti-mouse VEGF-A, pab 103-PA03 200 150 104
human sTIE-1/Fc Chimera SFC-012 100 285 94 anti-mouse VEGF-A, pab 103-PA03AG 50 175 104
anti-human TIE-1 (#6F12), mab 101-M48 100 230 94 anti-mouse VEGF-A, pab 103-P36 100 270 104
anti-human TIE-1 (#6F12) Biotin, mab 101-MBi48 50 230 94 anti-human VEGF-A (#3), mab 101-M59 100 230 104
anti-human TIE-1 (#8C9), mab 101-M46 100 230 94 anti-human VEGF-A (#3C5), mab 101-M56 100 230 104
mouse sTIE-1/Fc Chimera SFC-031 20 100 94 anti-human VEGF-A (#7G7), mab 101-M58 100 230 104
mouse sTIE-1/Fc Chimera SFC-032 100 285 94 human VEGF-A BIOLISA (active) DA-066 96-well 395 103
human sTIE-2/Fc Chimera SFC-013 20 100 94 human VEGF-A ELISA (total) DA-068 96-well 395 102
human sTIE-2/Fc Chimera SFC-014 100 285 94 mouse VEGF-A ELISA (total) DA-072 96-well 375 103
anti-human TIE-2 (#tek2), mab 101-M50 100 230 95 rat VEGF-C R20-014 5 95 104
anti-human TIE-2 (#tek2) Biotin, mab 101-MBi50 50 230 95 rat VEGF-C R20-015 20 220 104
anti-human TIE-2 (#tek9), mab 101-M52 100 230 95 anti-rat VEGF-C, pab 104-PA10S 100 150 106
anti-human TIE-2 (#tek9) Biotin, mab 101-MBi52 50 230 95 anti-rat VEGF-C, pab 104-PA10 200 225 106
anti-human TIE-2 (#tek16), mab 101-M54 100 230 95 human VEGF-C ELISA (total) DA-070 96-well 395 105
anti-human TIE-2 (#tek16) Biotin, mab 101-MBi54 50 230 95 rat VEGF-C ELISA (total) DA-074 96-well 395 105
mouse sTIE-2/Fc Chimera SFC-033 20 100 95 rat VEGF-C152S R20-016 5 90 105
mouse sTIE-2/Fc Chimera SFC-034 100 285 95 rat VEGF-C152S R20-017 20 195 105
human TL-1A 100-294 20 210 95 anti-rat VEGF-D, pab 104-PA12S 100 150 106
human TNF-alpha 300-027 10 55 96 anti-rat VEGF-D, pab 104-PA12 200 225 106
human TNF-alpha 300-028 50 135 96 orf-virus VEGF-E 300-044S 2 80 106
anti-human TNF-alpha, mab 101-M17 500 250 96 orf-virus VEGF-E 300-044 5 160 106
anti-human TNF-alpha, pab 102-P87 100 270 96 orf-virus VEGF-E 300-045 20 490 106
mouse TNF-alpha M10-041 20 210 96 orf-virus HB-VEGF-E 300-046S 5 160 107
anti-mouse TNF-alpha, pab 103-P35 100 270 96 orf-virus HB-VEGF-E 300-046 20 490 107
anti-mouse TNF-alpha, pab 103-P35G 100 270 96 human sVEGFR-1/Flt-1 (native) S01-009 5 50 107
rat TNF-alpha R20-013 20 210 96 human sVEGFR-1/Flt-1 (native) S01-010 20 140 107
anti-rat TNF-alpha, pab 104-P11 100 270 96 human sVEGFR.1/Flt-1 (D5) S01-011 5 50 107
human sTNF receptor type I 100-118 20 210 97 human sVEGFR.1/Flt-1 (D5) S01-012 20 140 107
anti-human TNF receptor type I, pab 102-P95 100 270 97 human sVEGFR.1/Flt-1 (D4) S01-013 5 125 108
human sTNF receptor type II 100-119 20 210 97 human sVEGFR.1/Flt-1 (D4) S01-014 20 240 108
anti-human TNF receptor type II, pab 102-P96 100 270 97 human sVEGFR.1/Flt-1 (D3) S01-015 5 125 108
human TNF-beta 100-108 20 210 96 human sVEGFR.1/Flt-1 (D3) S01-016 20 240 108
human TNF-beta 100-297 20 210 96 human sVEGFR-1(D7)-Fc Chimera SFC-005 10 75 108
anti-human TNF-beta, pab 102-P88 100 270 97 human sVEGFR-1(D7)-Fc Chimera SFC-006 50 235 108
human TPO 100-109S 2 55 98 anti-human VEGFR-1/Flt-1 (#EWC), mab 101-M24 100 250 109
human TPO 100-109 10 135 98 anti-human VEGFR-1/Flt-1 (#EIC), mab 101-M26 100 250 109
human TPO 100-109-SC 50 395 98 anti-human VEGFR-1/Flt-1 (#EWF), mab 101-M28 100 230 109
anti-human TPO, pab 102-P89 100 270 98 anti-human VEGFR-1 (#EWF), Biotin, mab 101-MBi28 50 230 109
mouse TPO M10-087 10 270 98 anti-human VEGFR-1/Flt-1 (#EWI), mab 101-M30 100 230 109
human sTRAIL R-1/DR4 S01-035 50 210 99 anti-human VEGFR-1/Flt-1, pab 102-PA20S 100 150 109
human sTRAIL R-2/DR5 S01-036 50 210 99 anti-human VEGFR-1/Flt-1, pab 102-PA20 200 225 109
human sTRAIL/Apo2L 100-301 50 210 98 human VEGFR-1 ELISA (total) DA-064 96-well 395 109
anti-human TRAIL/Apo2L, mab 101-M86 500 250 98 human sVEGFR-2/KDR (D7) S01-001 5 50 110
anti-human TRAIL/Apo2L, pab 102-P97 100 270 98 human sVEGFR-2/KDR (D7) S01-002 20 300 110
human TSLP 100-304 10 210 99 human sVEGFR-2/KDR-Fc Chimera SFC-007 10 75 110
human TWEAK 100-111 50 210 99 human sVEGFR-2/KDR-Fc Chimera SFC-008 50 235 110
anti-human TWEAK, pab 102-P90 100 270 100 anti-human VEGFR-2/KDR (#3), mab 101-M32 100 230 111
human sTWEAK receptor S01-037 25 210 100 anti-human VEGFR-2 (#3) Biotin, mab 101-MBi32 50 230 111
anti-human TWEAK receptor, pab 102-P98 100 270 100 anti-human VEGFR-2/KDR (#4), mab 101-M34 100 230 111
human VEGF 121 300-031S 2 80 100 anti-human VEGFR-2/KDR (#EIC), mab 101-M20 100 250 111
human VEGF 121 300-031 5 160 100 anti-human VEGFR-2 (#EIC) Biotin, mab 101-MBi20 50 250 111
human VEGF 121 300-032 20 490 100 anti-human VEGFR-2/KDR (#EWC), mab 101-M22 100 250 111
human VEGF 121 300-071S 2 70 100 anti-human VEGFR-2/KDR, pab 102-PA18 200 195 110
human VEGF 121 300-071 5 120 100 anti-human VEGFR-2/KDR, pab 102-PA19S 100 150 110
human VEGF 121 300-072 20 350 100 anti-human VEGFR-2/KDR, pab 102-PA19 200 225 110
human VEGF 145 300-033S 2 70 101 anti-human VEGFR-2/KDR, pab 102-PA19AG 50 175 110
human VEGF 145 300-033 5 130 101 anti-human VEGFR-2/sc-Fv, single chain 500-001 100 250 111
human VEGF 145 300-034 20 300 101 human sVEGFR-3/FLT-4 S01-017 10 140 112
mouse VEGF164 M30-001S 2 70 101 human sVEGFR-3/FLT-4 S01-018 50 300 112
mouse VEGF164 M30-001 5 130 101 human sVEGFR-3/Fc Chimera SFC-009 10 95 112
mouse VEGF164 M30-002 20 300 101 human sVEGFR-3/Fc Chimera SFC-010 50 265 112
mouse VEGF164 M10-043 10 210 101 anti-human VEGFR-3/FLT-4, pab 102-PA22AG 100 250 112
human VEGF 165 300-035S 2 70 102 anti-human VEGFR-3/FLT-4, pab 102-PA23S 100 150 112
human VEGF 165 300-035 5 130 102 anti-human VEGFR-3/FLT-4, pab 102-PA23 200 225 112
human VEGF 165 300-036 20 300 102 anti-human VEGFR-3/FLT-4, pab 102-PA23AG 50 175 112
human VEGF 165 300-075S 2 60 102 anti-human VEGFR-3/FLT-4, mab 101-M36 100 250 112
human VEGF 165 300-075 5 100 102
human VEGF 165 300-076 20 260 102
anti-human VEGF-A, pab 102-P91 100 270 104
anti-human VEGF-A, pab 102-P91G 100 270 104
anti-human VEGF-A, pab 102-PA02S 100 150 104

Copyright © 2002 GENTAUR Molecular Products
Last modified: 05/29/09